Reivindicaciones

1. ETM-305, having the following structure: <img class="EMIRef" id="454104533-ib0006" /> 2. ETM-204, having the following structure: <img class="EMIRef" id="454104533-ib0007" /> 3. ETM-775 having the following structure: <img class="EMIRef" id="454104533-ib0008" /> 4. The use of ETM-305 according to claim 1 in the preparation of a medicament for the treament of mammalian leukemia in patients in need of such treatment, said method comprising administering an effective amount of ETM-305 to said patient in unit dosage form. 5. The use of ETM-775 according to claim 3 in the preparation of a medicament for the treament of mammalian leukemia in patients in need of such treatment, said method comprising administering an effective amount of ETM-775 to said patient in unit dosage form. 6. The use of ETM-305 according to claim 1 in the preparation of a medicament for the treament of mammalian lung carcinoma in patients in need of such treatment, said method comprising administering an effective amount of ETM-305 to said patient in unit dosage form. 7. The use of ETM-775 according to claim 3 in the preparation of a medicament for the treament of mammalian lung carcinoma in patients in need of such treatment, said method comprising administering an effective amount of ETM-775 to said patient in unit dosage form. 8. The use of ETM-305 according to claim 1 in the preparation of a medicament for the treament of mammalian colon adenocarcinoma in patients in need of such treatment, said method comprising administering an effective amount of ETM-30S to said patient in unit dosage form. 9. The use of ETM-775 according to claim 3 in the preparation of a medicament for the treament of mammalian colon adenocarcinoma in patients in need of such treatment, said method comprising administering an effective amount of ETM-775 to said patient in unit dosage form. 10. The use of ETM-305 according to claim 1 in the preparation of a medicament for the treament of mammalian malignant melanoma in patients in need of such treatment, said method comprising administering an effective amount of ETM-305 to said patient in unit dosage form. 11. The use of ETM-775 according to claim 3 in the preparation of a medicament for the treament of mammalian malignant melanoma in patients in need of such treatment, said method comprising administering an effective amount of ETM-775 to said patient in unit dosage form. 12. A pharmaceutical composition comprising ETM-305 according to claim 1 and a pharmaceutically acceptable carrier, diluent or excipient. 13. A pharmaceutical composition comprising ETM-775 according to claim 3 and a pharmaceutically acceptable carrier, diluent or excipient.